Eriochem

Eriochem is a pharmaceutical company focused on the synthesis of active pharmaceutical ingredients and the production of liquid and lyophilized injectables in the field of oncology, adhering to the highest global quality standards. Founded in 2000 in Argentina, the company launched its first global strategic and commercial development plan. Over time, Eriochem expanded its operations to supply oncology medications to Latin America, Asia Pacific, Europe, and North America, including the United States. The company's main production facility is located in Paraná, Entre Ríos, Argentina, strategically positioned in the Mercosur corridor. Additionally, it has established a presence in Brazil through ERIOCHEM ZENITEC in the state of São Paulo, and in Uruguay through ERIOCHEM SZ in Canelones. Moreover, the company recently formed ERIOCHEM USA in Nevada, focusing on the registration and commercialization of drugs with U.S. approvals. The latest achievement is the establishment of ERIOMEX, a commercial office responsible for distribution and sales in Mexico. Eriochem's new primary focus for commercial and institutional development is the United States.